November 24, 2014 by Chain Drug Review
Issue 11-24-2014, News
SAN FRANCISCO — Health Mart is hosting its second series of town hall meetings, “Pharmacy Quality Measures: Action Steps for Improvement.” The events will be held in 108 cities nationwide through early 2015. Designed to help pharmacies recognize the importance of Five-Star Quality Ratings (as established by the Centers for Medicare & Medicaid Services) and
November 24, 2014 by Chain Drug Review
Issue 11-24-2014, News
ARLINGTON, Va. — The National Association of Chain Drug Stores has hired Sara Rubin as manager of pharmacy care. In this position, Rubin will be responsible for supporting the development and implementation of NACDS pharmacy care initiatives. She reports to Alex Adams, vice president of pharmacy programs. In addition, Rubin will provide analysis of emerging
November 24, 2014 by Chain Drug Review
Issue 11-24-2014, News
BENTONVILLE, Ark. — Yale Martin, senior category director of O-T-C merchandising at Walmart, has retired after 18 years with the company. In that role, Martin led a team of buyers responsible for merchandising over-the-counter products for Walmart’s 5,000 stores in the United States. He also contributed to the launch of the 88 cents O-T-C program and
November 24, 2014 by Chain Drug Review
Issue 11-24-2014, News
FLINT, Mich. — Martino Luu has been appointed vice president of innovation and process improvement at Diplomat Pharmacy Inc. Luu will work with Diplomat’s business units to carry out evaluations of current processes as well as make recommendations for improvements designed to sharpen efficiency. The company is the largest independent specialty pharmacy in the United
November 24, 2014 by Chain Drug Review
Issue 11-24-2014, Opinion
As the Christmas selling season begins, it’s becoming increasingly apparent that mass retailers are concerned about business. Not that they have nothing to offer their customers; rather, they have little to offer that’s exciting, new, different, compelling, or even mildly interesting. That being the case, retailers are turning to other inducements to attract traffic: price
November 24, 2014 by Chain Drug Review
Issue 11-24-2014, Opinion
The Republican wave that swept across the country in this month’s midterm elections transformed the political landscape and raised hopes, however fragile, that the gridlock that has come to characterize Washington in recent years might be alleviated, if not completely overcome. Business groups are eager to work with the 114th Congress, where they are confident
November 21, 2014 by Chain Drug Review
Supplier News
DUBLIN, Ohio, and MELVILLE, N.Y. — Cardinal Health Inc. has entered a long-term agreement in which it will consolidate its physician office commercial organization into the medical group of health care supplier Henry Schein Inc. Under the deal, announced Friday, Henry Schein also has committed to buy Cardinal Health-brand products and use Cardinal as a
November 21, 2014 by Chain Drug Review
Supplier News
STAMFORD, Conn. — Purdue Pharma L.P. has received approval from the Food and Drug Administration for Hysingla ER (hydrocodone bitartrate) extended-release tablets CII, an opioid pain reliever. Purdue said Thursday that the once-daily, single-entity medication is formulated using its Resistec proprietary ER solid oral platform. According to the company, Hysingla ER is the first and
November 20, 2014 by Chain Drug Review
Supplier News
PLANO, Texas — Jim Norred has been appointed as president of the Marketing Solutions Group at Crossmark. Jim Norred The sales and marketing firm said Thursday that Norred will lead a group that provides insight-driven marketing solutions to address the day-to-day challenges that brands experience. The business unit includes integrated engagement marketing expertise via Marketing
November 20, 2014 by Chain Drug Review
Supplier News
HYDERABAD, India — Dr. Reddy’s Laboratories has announced the U.S. rollout of over-the-counter fexofenadine hydrochloride and pseudoephedrine hydrochloride extended-release tablets 60 mg/120 mg, a cold/allergy medication. Dr. Reddy’s said Thursday that its product, available in a 20-count blister package, is a bioequivalent generic version of Allegra-D 12-Hour Allergy & Congestion ER tablets from Chattem Inc.
November 20, 2014 by Chain Drug Review
Supplier News
ALISO VIEJO, Calif. — SensatioNail has signed actress Gabrielle Union as its first celebrity brand ambassador and creative advisor. The Pacific World Cosmetics at-home gel polish brand said Thursday that Union, over the multiyear partnership, will be featured in the brand’s 2014-15 commercial advertising campaign and participate across public relations and marketing activities. SensatioNail’s exclusive
November 20, 2014 by Chain Drug Review
Supplier News
STOCKHOLM, Sweden — Moberg Pharma AB has named Jeff Vernimb as general manager of its U.S. operations. The Sweden-based pharmaceutical company said Thursday that Vernimb’s appointment, effective Dec. 15, also makes him a member of Moberg’s management team. Vernimb brings more than 25 years of experience in consumer health products marketing and sales to Moberg.
November 20, 2014 by Chain Drug Review
Supplier News
BRIDGEWATER, N.J. — Amneal Pharmaceuticals LLC has launed Lopreeza tablets (estradiol/norethindrone acetate), a menopause medication, in 0.5 mg/0.1 mg and 1 mg/0.5 mg strengths. Amneal said Thursday that Lopreeza is the first authorized generic version of Novo Nordisk’s Activella and contains the identical formulation of estradiol/norethindrone acetate. Both strengths of Lopreeza are now shipping, according
November 20, 2014 by Chain Drug Review
Supplier News
BRIDGEWATER, N.J. — Matrixx Initiatives Inc. has introduced Zicam Kids, a homeopathic cold medicine designed to provide symptom relief for children ages 6 to 11. Matrixx said Thursday that Zicam Kids, which comes in a grape-flavored soft chew, delivers safe, nondrowsy and effective relief of nasal congestion, runny nose and scratchy throat. American children have